Fortis Healthcare FORTIS
Pan-India hospital chain promoted by Malaysia's IHH Healthcare, plus Agilus Diagnostics (~89% owned), one of India's largest pathology networks
Mapped in 1 theme: Hospitals & Healthcare.
Where Fortis Healthcare sits in the supply chain
Fortis Healthcare appears in 2 supply-chain layers in one theme, Hospitals & Healthcare.
Hospitals & Healthcare › Multi-specialty hospital chains
OperatorOther companies in this layer
Hospitals & Healthcare › Pathology labs
OperatorOther companies in this layer
Revenue and profit
| ₹ Cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 5,718 | 6,298 | 6,893 | 7,783 | 9,128 |
| Net profit | 790 | 633 | 645 | 809 | 1,064 |
Latest-year revenue ₹9,128 Cr (FY26, company-wide).
Note: Group figures include Agilus Diagnostics.
Strengths
- Margin recovery under IHH: hospital EBITDA margins have risen steadily since FY22
- Bolt-on acquisitions add beds in core clusters - Shrimann (Jalandhar, 2025) and People Tree (Bengaluru, agreed Dec 2025, ₹430 Cr)
- Higher government-scheme share made it one of the expected gainers from the Oct 2025 CGHS revision (Nuvama)
Risks
- Legacy litigation from the former promoters and IHH's pending open offer
- Agilus diagnostics faces the same price competition as other lab chains
- Older hospitals need refurbishment capex
Common questions
What does Fortis Healthcare do?
Pan-India hospital chain promoted by Malaysia's IHH Healthcare, plus Agilus Diagnostics (~89% owned), one of India's largest pathology networks.
Where does Fortis Healthcare sit in the supply chain?
Fortis Healthcare (NSE: FORTIS) is mapped in 2 supply-chain layers: Multi-specialty hospital chains (Hospitals & Healthcare) and Pathology labs (Hospitals & Healthcare).
Who are Fortis Healthcare's peers?
In the Multi-specialty hospital chains layer of Hospitals & Healthcare: Apollo Hospitals Enterprise, Max Healthcare Institute, Manipal Health Enterprises (Manipal Hospitals), Global Health (Medanta), Narayana Hrudayalaya (Narayana Health), Aster DM Quality Care and 5 more.
What is Fortis Healthcare's market cap and valuation?
As of 6 Nov 2026: market cap ₹57,884 Cr, P/E 54.0x, ROCE 13.4%, ROE 11.2%, dividend yield 0.13%.